Cargando…
LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC
BACKGROUND: Dysregulation of transcription and cytokine expression has been implicated in the pathogenesis of a variety inflammatory diseases. The resulting imbalance between inflammatory and resolving transcriptional programs can cause an overabundance of pro-inflammatory, classically activated mac...
Autores principales: | Thomas, Gregory, Frederick, Elizabeth, Thompson, Lisa, Bar-Or, Raphael, Mulugeta, Yetti, Hausburg, Melissa, Roshon, Michael, Mains, Charles, Bar-Or, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702209/ https://www.ncbi.nlm.nih.gov/pubmed/33256749 http://dx.doi.org/10.1186/s12967-020-02626-z |
Ejemplares similares
-
AMP5A modulates Toll-like receptors 7 and 8 single-stranded RNA immune responses in PMA-differentiated THP-1 and PBMC
por: Thomas, Gregory, et al.
Publicado: (2022) -
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis
por: Thomas, Gregory, et al.
Publicado: (2020) -
The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
por: Rael, Leonard T., et al.
Publicado: (2018) -
C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?
por: Hausburg, Melissa A., et al.
Publicado: (2022) -
Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis
por: Hausburg, Melissa A., et al.
Publicado: (2020)